jRCT2071230074
Untitled Trial
A PHASE I, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF REVN24 IN HEALTHY MALE VOLUNTEERS
Chugai Pharmaceutical Co., Ltd.·Japan Registry Clinical TrialRecruiting
Study focus
- Disease/Condition
- Healthy Volunteer
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Chugai Pharmaceutical Co., Ltd.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Healthy person accompanying sick personRoutine general health check-up of armed forcesPersons encountering health services in other circumstancesPersons encountering health services in other circumstancesPerson encountering health services in unspecified circumstances
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT2071230074
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT2071230074 through Pure Global AI's free database. This phase not specified trial is sponsored by Chugai Pharmaceutical Co., Ltd. and is currently Recruiting. The study focuses on Healthy Volunteer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.